AIRS
Airsculpt Technologies IncKey Statistics
About Airsculpt Technologies Inc
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure, which provides minimally invasive body contouring solutions. The company prioritizes patient safety and comfort while delivering remarkable aesthetic outcomes, thereby transforming the cosmetic surgery experience. With a robust network of licensed practitioners and a strong commitment to technological advancement, Airsculpt is strategically positioned to capitalize on the increasing global demand for non-invasive cosmetic procedures, aiming to enhance its market presence and diversify its offerings. This proactive approach not only drives immediate growth but also sets the foundation for sustainable long-term value creation for its investors.
Fundamentals
| Revenue (TTM) | $151.82M |
| Gross Profit (TTM) | $100.13M |
| EBITDA | $7.95M |
| Operating Margin | -4.56% |
| Return on Equity | -14.10% |
| Return on Assets | -1.51% |
| Revenue/Share (TTM) | $2.51 |
| Book Value | $1.36 |
| Price-to-Book | 2.26 |
| Price-to-Sales (TTM) | 1.44 |
| EV/Revenue | 1.798 |
| EV/EBITDA | 223.62 |
| Quarterly Earnings Growth (YoY) | 200.00% |
| Quarterly Revenue Growth (YoY) | -14.60% |
| Shares Outstanding | $70.55M |
| Float | $3.18M |
| % Insiders | 32.54% |
| % Institutions | 67.65% |